Aquino at the Congress hearing.
And why did they do this? The only rational answer is this: None of the country’s most prevalent diseases and causes of mortality involved a new drug or vaccine offered solely by a single firm, as the French company Sanofi did in the case of its Dengvaxia, so far the only such vaccine claimed to prevent dengue.